Market Tracker

10/24 6:05pm ET

Impax Laboratories Inc (NASDAQ:IPXL)

27.80
Data as of Oct 24
 0.00 / 0.00%
Today’s Change
19.67
Today|||52-Week Range
31.04
+10.58%
Year-to-Date

Today’s Trading

Previous close27.80
Today’s open27.89
Day’s range27.54 - 28.00
Volume322,174
Average volume (3 months)744,322
Market cap$2.0B
Dividend yield--
Data as of 3:59pm ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)+79.27%
Earnings growth (this year)+38.71%
Earnings growth (next 5 years)+26.50%
Revenue growth (last year)-12.07%
P/E ratio1,390.0
Price/Sales3.29
Price/Book2.39

Competitors

 Today’s
change
Today’s
% change
THRXTheravance Inc-0.09-0.52%
IRWDIronwood Pharmaceuti...-0.04-0.30%
CLVSClovis Oncology Inc+1.53+2.83%
RCPTReceptos Inc+2.90+4.50%
Data as of 3:59pm ET, 10/24/2014

Financials

Next reporting dateNovember 4, 2014
EPS forecast (this quarter)$0.31
Annual revenue (last year)$511.5M
Annual profit (last year)$101.3M
Net profit margin19.80%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
George Frederick Wilkinson
Chief Financial Officer &
Senior VP-Finance
Bryan M. Reasons
Corporate headquarters
Hayward, California

Forecasts